Quanticate Expands their Global Operations for Biostatistics and Programming in Clinical Trials
Bangalore and North Carolina facilities look to expand staff after the award of two large FSPs
Quanticate, a leading global data-focused clinical research organization (CRO) today announced the expansion of its global resources to support clinical trials. The region most affected is Bangalore and North Carolina, particularly in the areas of biostatistics and statistical programming, following the award of large functional service provision (FSP) contracts with two industry-leading pharmaceutical companies.
Quanticate is looking to significantly grow its resource capabilities and will be recruiting staff over a range of roles in biostatistics and statistical programming across all levels of seniority throughout 2014 based upon its overall pipeline of work. Opportunities will include graduate to principal roles in India and the US as well as other global locations.
"The expansion of our current customers coupled with the addition of new partnerships and two large-scale FSPs, has resulted in the need to expand our resource base across all our locations,” explained Daniel Chapple, Chief Commercial Officer. “This expansion will also enable us to extend our presence to other cities in India and we are currently in the process of identifying facilities,” continued Chapple.
The addition of two new partnerships means that Quanticate is now supporting biostatistics and programming for six of the Top 8 pharmaceutical companies and has gained extensive experience in successfully supporting companies in strategic partnerships within the data field. “Many companies are seeing the benefits from companies that can offer global expertise in their niche fields rather than using full service CROs whose primary focus is monitoring and project management,” explains David Underwood, CEO of Quanticate. Underwood continues, “This approach can also drastically reduce operational oversight on the client side where successful partnerships are built on quality, performance, trust and understanding. It also means clients gain from the big benefit of having subject experts supporting their programs of work.”
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
